Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
RISPERIDONE-CONTAINING MICROCAPSULE, METHOD FOR MANUFACTURING SAME AND RELEASE CONTROL METHOD
Document Type and Number:
WIPO Patent Application WO/2017/043494
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a microcapsule, said microcapsule containing a biodegradable polymer and risperidone and having excellent sustained release properties, and a method for manufacturing the same. A microcapsule containing a biodegradable polymer and risperidone, characterized in that the biodegradable polymer in the microcapsule has a molecular weight (Mw) corresponding to 85% or greater relative to the starting Mw thereof; a method for manufacturing a microcapsule that comprises (A) a step for mixing a biodegradable polymer solution and a risperidone solution, said solutions having been prepared separately, to prepare a first phase, (B) a step for, immediately after preparing the first phase, mixing the first phase with a second phase that is an aqueous phase to prepare an emulsion, and (C) a step for drying the obtained emulsion in water; and a method for controlling the release of risperidone from a microcapsule containing a biodegradable polymer and risperidone, characterized in that the Mw of the biodegradable polymer in the microcapsule is adjusted to 85% or greater relative to the starting Mw thereof.

Inventors:
KOSAKA NAOYA (JP)
MIYANAGA NAOYUKI (JP)
HATSUSHIKA MINORU (JP)
Application Number:
PCT/JP2016/076198
Publication Date:
March 16, 2017
Filing Date:
September 06, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NIPRO CORP (JP)
International Classes:
A61K31/519; A61K9/52; A61P25/18; A61P43/00
Foreign References:
JP2003534268A2003-11-18
JP2016102093A2016-06-02
JP2014512396A2014-05-22
JPH09505308A1997-05-27
Other References:
SU, ZHENGXING ET AL.: "Effects of Formulation Parameters on Encapsulation Efficiency and Release Behavior of Risperidone Poly(D,L- lactide-co-glycolide) Microsphere", CHEM. PHARM. BULL., vol. 57, no. 11, November 2009 (2009-11-01), pages 1251 - 1256, XP055144767
Attorney, Agent or Firm:
ASAHINA & CO. (JP)
Download PDF: